Orphanet Journal of Rare Diseases (Jan 2019)

Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders

  • Jana Pospiskova,
  • Lukas Smolej,
  • David Belada,
  • Martin Simkovic,
  • Monika Motyckova,
  • Alice Sykorova,
  • Pavla Stepankova,
  • Pavel Zak

DOI
https://doi.org/10.1186/s13023-018-0991-3
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 7

Abstract

Read online

Abstract Background Chylothorax is a rare condition which can be associated with malignant lymphoproliferative disorders (LPDs). We retrospectively analyzed the results of the conservative treatment of 10 patients with persistent non-traumatic malignant chylothorax. Results Conservative treatment lead to a decline of chylothorax after mean of 66 days and consisted of the treatment of the underlying disease and of simultaneous long-term supportive care (drainage of the thoracic cavity, dietary measures and nutrition management). In most cases (80%), chylothorax disappeared only after a successful therapeutic response of the underlying disease. Low-dose radiotherapy had very good effects in two patients. Conclusion Conservative treatment of malignant chylothorax can be considered a suitable method. Based on our results, successful treatment of the lymphoproliferative disorder seems to be a very important factor for the disappearance of chylothorax.

Keywords